In contrast to primary or immortalised osteoblasts, which normally have low RUNX2 levels, loss of p53 correlates with elevated RUNX2 protein levels in several growth factor-independent osteosarcoma cell lines [26, 27]. This evidence concerns the gene RUNX2 and osteosarcoma.